Maryland Stem Cell Research Fund (MSCRF) was established by the governor and the Maryland General Assembly under the Maryland Stem Cell Research Act of 2006. The purpose of the fund is to promote state-funded human stem cell research and medical treatments through grants to public and private entities in the state.
MSCRF offers six programs (Launch, Discovery, Validation, Commercialization, Clinical and Post-doctoral Fellowships) to accelerate research and commercialization of human stem cell-based technologies. For eligibility and to apply visit MSCRF funding opportunities.
Useful Documents
Public Notices
April 25 & May 2, 2022
March 7, 2022
January 10, 2022
November 1, 2021
September 13, 2021
August 23, 2021
July 12, 2021
May 4, 2021
April 30, 2021
March 1, 2021
January 4, 2021
November 2, 2020
September 9, 2020
July 7, 2020
June 2, 2020
March 16, 2020
January 14, 2020
November 4, 2019
September 5, 2019
August 8, 2019
July 1, 2019
May 6, 2019
March 4, 2019
Administrative Documents
Conflict of Interest
Maryland Stem Cell Scientific Peer Review Committee Member CDA
MSCR Commission Member CDA
Template of Research Grant Agreement
Maryland Stem Cell Economic Study
Maryland Stem Cell Economic Study – 2021
For Additional Fund Information
MSCRF Annual Reports
Maryland Stem Cell Research Commission
Chair
Debra Mathews, Johns Hopkins Berman Institute of Bioethics
Vice Chair
Diane Hoffman, University of Maryland School of Law
Members
Ira Schwartz, Office of the Attorney General
Scott Bailey, Johns Hopkins School of Medicine
Rachel Brewster, University of Maryland, Baltimore County
Margaret Conn Himelfarb, Johns Hopkins Bloomberg School of Public Health
Haig Kazazian, Jr., McKusick-Nathans Institute of Genetic Medicine
David Mosser, University of Maryland, College Park
Barbara Nsiah, United Therapeutics
Linda Powers, Toucan Capital
Rabbi Avram Reisner, Congregation Chevrei Tzedek
Curtis Van Tassell, Research Geneticist